Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Other Non Operating Income (2025)

Historic Other Non Operating Income for Madrigal Pharmaceuticals (MDGL) over the last 3 years, with Q3 2025 value amounting to -$2.8 million.

  • Madrigal Pharmaceuticals' Other Non Operating Income changed N/A to -$2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.8 million, marking a year-over-year change of. This contributed to the annual value of $273000.0 for FY2021, which is N/A changed from last year.
  • Latest data reveals that Madrigal Pharmaceuticals reported Other Non Operating Income of -$2.8 million as of Q3 2025.
  • Madrigal Pharmaceuticals' 5-year Other Non Operating Income high stood at -$42000.0 for Q2 2025, and its period low was -$2.8 million during Q3 2025.